BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay ...

People with diplomatic immunity in the UK allegedly committed offences including sexual assault, indecent exposure and child cruelty last year, a British government minister said on Thursday.

The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.

“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...